credits bmbl December 7 '06.doc - Central Michigan University

More documents

Recommendations

Info

Agent Summary Statements – Arboviruses and Related Zoonotic Viruses TAXONOMIC STATUS (FAMILY OR GENUS) RECOMMENDED BIOSAFETY LEVEL BASIS OF RATING ANTIGENIC NAME ACRONYM GROUP Getah GETV Alphavirus 2 A1 A f No Gomoka GOMV Orbivirus 2 S Ieri No Gordil GORV Phlebovirus 2 IE Phlebotomus Fever No Gossas GOSV Rhabdoviridae 2 S No Grand Arbaud GAV Phlebovirus 2 S Uukuniemi No Gray Lodge GLOV Vesiculovirus 2 IE Vesicular Stomatitis No Great Island GIV Orbivirus 2 S Kemerovo No Guajara GJAV Orthobunyavirus 2 S Capim No Guama GMAV Orthobunyavirus 2 S Guama No Guanarito GTOV Arenavirus 4 A4 Tacaribe Yes Guaratuba GTBV Orthobunyavirus 2 A7 Guama No Guaroa GROV Orthobunyavirus 2 S California No Gumbo Limbo GLV Orthobunyavirus 2 S C f No Gurupi GURV Orbivirus 2 IE Changuinola No Hantaan HTNV Hantavirus 3 a S Hantaan No Hanzalova HANV Flavivirus 4 A4 B f Yes Hart Park HPV Rhabdoviridae 2 S Hart Park No Hazara HAZV Nairovirus 2 S CHF-Congo No Highlands J HJV Alphavirus 2 S A f No Huacho HUAV Orbivirus 2 S Kemerovo No Hughes HUGV Nairovirus 2 S Hughes No Hypr HYPRV Flavivirus 4 S B f Yes Iaco IACOV Orthobunyavirus 2 IE Bunyamwera No Ibaraki IBAV Orbivirus 2 IE Epizootic Hemorrhagic Disease Yes Icoaraci ICOV Phlebovirus 2 S Phlebotomus Fever No Ieri IERIV Orbivirus 2 S Ieri No HEPA FILTRATION ON LAB EXHAUST 268
Agent Summary Statements – Arboviruses and Related Zoonotic Viruses TAXONOMIC STATUS (FAMILY OR GENUS) RECOMMENDED BIOSAFETY LEVEL BASIS OF RATING ANTIGENIC NAME ACRONYM GROUP Ife IFEV Orbivirus b 2 IE No Iguape IGUV Flavivirus 2 A7 B f No Ilesha ILEV Orthobunyavirus 2 S Bunyamwera No Ilheus ILHV Flavivirus 2 S B f No Ingwavuma INGV Orthobunyavirus 2 S Simbu No Inhangapi INHV Rhabdoviridae 2 IE No Inini INIV Orthobunyavirus 2 IE Simbu No Inkoo INKV Orthobunyavirus 2 S California No Ippy IPPYV Arenavirus 2 S Tacaribe No Iriri IRRV Rhabdoviridae 2 A7 No Irituia IRIV Orbivirus 2 S Changuinola No Isfahan ISFV Vesiculovirus 2 S Vesicular Stomatitis No Israel Turkey Meningitis ITV Flavivirus 2 with 3 practices S B f No Issyk-Kul ISKV Bunyaviridae 3 IE No Itacaiunas ITCNV Rhabdoviridae 2 A7 No Itaituba ITAV Phlebovirus 2 IE Phlebotomus Fever No Itaporanga ITPV Phlebovirus 2 S Phlebotomus Fever No Itaqui ITQV Orthobunyavirus 2 S C f No Itimirim ITIV Orthobunyavirus 2 IE Guama No Itupiranga ITUV Orbivirus b 2 IE No Ixcanal IXCV Phlebovirus 2 A7 Phlebotomus Fever No Jacareacanga JACV Orbivirus 2 IE Corriparta No Jacunda JCNV Phlebovirus 2 A7 Phlebotomus Fever No Jamanxi JAMV Orbivirus 2 IE Changuinola No Jamestown Canyon JCV Orthobunyavirus 2 S California No Japanaut JAPV Orbivirus b 2 S No Japanese Encephalitis JEV Flavivirus 3 c S B f No HEPA FILTRATION ON LAB EXHAUST 269
Page 1 and 2:
Biosafety in Microbiological and Bi
Page 3 and 4:
SECTION VIII-H: Prion Diseases 299
Page 5 and 6:
Forward Biosafety in Microbiologica
Page 7 and 8:
Editors: L. Casey Chosewood, MD Dir
Page 9 and 10:
Guest Editors: Matthew J. Arduino,
Page 11 and 12:
Charles B. Millard, PhD Lieutenant
Page 13 and 14:
Robert Bull Karen B. Byers Jane Cap
Page 15 and 16:
Thomas L. Miller Douglas M. Moore M
Page 17 and 18:
Robert Yarchoan Uri Yokel Lisa Youn
Page 19 and 20:
Introduction laboratories chose not
Page 21 and 22:
Introduction RISK CRITERIA FOR ESTA
Page 23 and 24:
Introduction BMBL includes an impor
Page 25 and 26:
Section II Biological Risk Assessme
Page 27 and 28:
Biological Risk Assessment informat
Page 29 and 30:
Biological Risk Assessment The NIH
Page 31 and 32:
Biological Risk Assessment effectiv
Page 33 and 34:
Biological Risk Assessment Third, m
Page 35 and 36:
Biological Risk Assessment 14. Oxma
Page 37 and 38:
Principles of Biosafety Safety equi
Page 39 and 40:
Principles of Biosafety Often an in
Page 41 and 42:
Principles of Biosafety Four standa
Page 43 and 44:
Principles of Biosafety 4. Centers
Page 45 and 46:
Laboratory Biosafety Level Criteria
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Section V Vertebrate Animal Biosafe
Page 77 and 78:
Vertebrate Animal Biosafety Level C
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
TABLE 1 SUMMARY OF RECOMMENDED BIOS
Page 121 and 122:
Principles of Laboratory Biosecurit
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Occupational Health and Immunoproph
Page 134 and 135:
Page 137 and 138:
Page 139 and 140:
Agent Summary Statements - Bacteria
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
• Section VIII-B: Fungal Agents A
Page 187 and 188:
Agent Summary Statements - Fungal A
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
• Section VIII-C: Parasitic Agent
Page 199 and 200:
Agent Summary Statements - Parasiti
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
• Section VIII-D: Rickettsial Age
Page 211 and 212:
Agent Summary Statements - Ricketts
Page 213 and 214:
Agent Summary Statements - Ricketts
Page 215 and 216:
• Section VIII-E: Viral Agents Ag
Page 217 and 218: Agent Summary Statements - Viral Ag
Page 245 and 246: Agent Summary Statements - Arboviru
Page 267: Agent Summary Statements - Arboviru
Page 285 and 286: • Section VIII-G: Toxin Agents Se
Page 287 and 288: Agent Summary Statements - Toxins i
Page 289 and 290: Agent Summary Statements - Toxins A
Page 291 and 292: Agent Summary Statements - Toxins L
Page 293 and 294: Agent Summary Statements - Toxins e
Page 295 and 296: Agent Summary Statements - Toxins o
Page 297 and 298: Agent Summary Statements - Toxins t
Page 299 and 300: • Section VIII-H: Prion Diseases
Page 301 and 302: Agent Summary Statement - Prion Dis
Page 307 and 308: Appendix A Proper maintenance of ca
Page 309 and 310: Appendix A declined. However, in ma
Page 311 and 312: Appendix A It is possible to exhaus
Page 313 and 314: Appendix A 4. The Class II, Type A2
Page 315 and 316: Appendix A prohibited. Furthermore,
Page 317 and 318: Appendix A plastic wrappers, pipett
Page 319 and 320:
Appendix A touch-plate microburners
Page 321 and 322:
Appendix A SECTION VI FACILITY AND
Page 323 and 324:
Appendix A Development of Containme
Page 325 and 326:
Appendix A C. Airflow Smoke Pattern
Page 327 and 328:
Appendix A TABLES Table 1. Selectio
Page 329 and 330:
Appendix A Table 3. Field Performan
Page 331 and 332:
Appendix A FIGURES Figure 1. HEPA f
Page 333 and 334:
Appendix A Figure 3. The Class II,
Page 335 and 336:
Appendix A Figure 5B. The Class II,
Page 337 and 338:
Appendix A Figure 8. The Class III
Page 339 and 340:
Appendix A Figure 9B. The vertical
Page 341 and 342:
Appendix A Figure 11. A typical lay
Page 343 and 344:
Appendix A REFERENCES 1. Centers fo
Page 345 and 346:
Appendix B Decontamination and Disi
Page 347 and 348:
Appendix B surfaces are contaminate
Page 349 and 350:
Appendix B TABLE 1 DESCENDING ORDER
Page 351 and 352:
Appendix B dioxide gas exits the ge
Page 353 and 354:
Appendix B d The effectiveness of a
Page 355 and 356:
Appendix C Transportation of Infect
Page 357 and 358:
Appendix C 1600 Clifton Road, N.E.,
Page 359 and 360:
Appendix C disease in humans or in
Page 361 and 362:
Appendix C Biological specimen, Cat
Page 363 and 364:
Appendix D Agriculture Pathogen Bio
Page 365 and 366:
Appendix D simultaneous opening of
Page 367 and 368:
Appendix D 14. Pathological inciner
Page 369 and 370:
Appendix D Wastes and other materia
Page 371 and 372:
Appendix D Camelpox virus b a, b, c
Page 373 and 374:
Appendix D SPECIAL ISSUES The impor
Page 375 and 376:
Appendix D required by the USDA and
Page 377 and 378:
Appendix D depression, anorexia, an
Page 379 and 380:
Appendix D laboratory with enhancem
Page 381 and 382:
Appendix D five day period of conta
Page 383 and 384:
Appendix D slaughterhouses or indus
Page 385 and 386:
Appendix D virus does not cause any
Page 387 and 388:
Appendix D NDV is classified in the
Page 389 and 390:
Appendix D movement permit is requi
Page 391 and 392:
Appendix D Spring Viremia of Carp V
Page 393 and 394:
Appendix D REFERENCES 1. Hess WR. A
Page 395 and 396:
Appendix D 37. Alexander DJ. Newcas
Page 397 and 398:
Appendix E Arthropod Containment Gu
Page 399 and 400:
Appendix F Select Agents and Toxins
Page 401 and 402:
Appendix G IPM issues and requireme
Page 403 and 404:
Appendix H Working with Human, NHP
Page 405 and 406:
Appendix I Guidelines for Work with
Page 407 and 408:
decontaminated periodically, for ex
Page 409 and 410:
0.25N, and/or sodium hypochlorite (
Page 411 and 412:
k Irradiation causes a dose-depende
Page 413 and 414:
7. Morin R, Kozlovac J. Biological
Page 415 and 416:
Appendix J NIH Oversight of Researc
Page 417 and 418:
Appendix K Resources for Informatio
Page 419 and 420:
Appendix K E-mail: http://www2.gsu.
Page 421 and 422:
Appendix K and http://www.who.int/c
Page 423 and 424:
Appendix L HEPA High Efficiency Par
show all

credits bmbl December 7 '06.doc - Central Michigan University

Create successful ePaper yourself

Delete template?

Save as template?